Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selonsertib + Prednisolone in Severe Alcoholic Hepatitis
NCT02854631Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of selonsertib in alcoholic hepatitis (AH), sponsored by Gilead Sciences. Started Sep 2016; status: completed.
02
Drugs
selonsertib
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT02854631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02854631.